Toshiyuki Tomoo

Amyloid β2-microglobulin is modified with Nε-(carboxymethyl)lysine in dialysis-related amyloidosis

Toshimitsu Niwa, Mitsuhiko Sato, Tomoyuki Katsuzaki et al. · Kidney International · 1996 · 66 citations

Life Sciences, Biochemistry, Nephrology +11

Small-molecule inhibition of PTPRZ reduces tumor growth in a rat model of glioblastoma

Akihiro Fujikawa, Asako Nagahira, Hajime Sugawara et al. · Scientific Reports · 2016 · 58 citations · Full text

Medicine, Oncology, Pharmacology +14

Design, Synthesis, and Biological Evaluation of 3-(1-Aryl-1<i>H</i>-indol-5-yl)propanoic Acids as New Indole-Based Cytosolic Phospholipase A₂α Inhibitors

Toshiyuki Tomoo, Takashi Nakatsuka, Toyoko Katayama et al. · Journal of Medicinal Chemistry · 2014 · 54 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

An efficient short-step total synthesis of ganglioside GM3: effective usage of the neighbouring group participation strategy

Toshiyuki Tomoo, Tadao Kondo, Hiroyuki Abé et al. · Carbohydrate Research · 1996 · 43 citations

Life Sciences, Biotechnology, Glycobiology +4

ASB14780, an Orally Active Inhibitor of Group IVA Phospholipase A2, Is a Pharmacotherapeutic Candidate for Nonalcoholic Fatty Liver Disease

Shiho Kanai, Keiichi Ishihara, Eri Kawashita et al. · Journal of Pharmacology and Experimental Therapeutics · 2015 · 38 citations

Medicine, Pharmacology, Pharmacotherapy +17